UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000032379
Receipt No. R000036927
Official scientific title of the study Evaluation of baroreflex function by novel noninvasive medical instruments in chronic heart failure patients and healthy subjects Pilot test
Date of disclosure of the study information 2018/04/26
Last modified on 2018/08/07 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Evaluation of baroreflex function by novel noninvasive medical instruments in chronic heart failure patients and healthy subjects Pilot test
Title of the study (Brief title) Pilot study for baroreflex evaluetion in CHF patients
Region
Japan

Condition
Condition Chronic heart failure patients
Healthy subjects
Classification by specialty
Cardiology Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Evaluation of baroreflex function from arterial pressure waveform obtained with novel noninvasive device in chronic heart failure patients and healthy subjects.
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Baroreflex function evaluate from arterial waveform
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Prevention
Type of intervention
Device,equipment
Interventions/Control_1 Use of unapproved equipment (wrist type continuous blood pressure monitor) 30 minutes once
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Healthy subjects
Age is 20 years or older at the time of acquiring consent
Who have not been diagnosed heart failure and arrhythmia in the past half year and who have not undergone regular medical treatment
Who got document agreement by voluntary free will after fully understanding after participating in this exam

For patients with chronic heart failure,
Age is 20 years or older at the time of acquiring consent
Patients with chronic heart failure (those with a left ventricular contractility of less than 50% in transthoracic echocardiography)
A person equivalent to I to II degrees in NYHA classification
Persons who have no history of hospitalization in the past 3 months and have stable disease condition
Person who got document agreement by voluntary free will after fully understanding after participating in this exam
Key exclusion criteria Those who satisfy one of the following items are excluded.
Atrial fibrillation
Poor control diabetes (HbA1c> 7%)
Undergoing pacemaker implantation for arrhythmia
Epilepsy
During pregnancy, breast-feeding, who may be pregnant
Under dialysis
Skin trouble on upper arm and wrist, who can not measure blood pressure
Judged inappropriate by the examining physician
Others who are difficult to complete this test protocol
Target sample size 30

Research contact person
Name of lead principal investigator Tomomi Ide
Organization Kyushu University
Division name Departments of Cardiovascular Medicine
Address 3-1-1 Maidashi, Higashi-ku, Fukuoka
TEL 092-642-6439
Email tomomi_i@cardiol.med.kyushu-u.ac.jp

Public contact
Name of contact person Keita Saku
Organization Kyushu University
Division name Center for Disruptive Cardiovascular Medicine
Address 3-1-1 Maidashi, Higashi-ku, Fukuoka
TEL 092-642-6439
Homepage URL
Email saku@cardiol.med.kyushu-u.ac.jp

Sponsor
Institute Kyushu University
Institute
Department

Funding Source
Organization Japan Agency for Medical Research and Development
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 04 Month 26 Day

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2018 Year 03 Month 27 Day
Anticipated trial start date
2018 Year 05 Month 02 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2018 Year 04 Month 25 Day
Last modified on
2018 Year 08 Month 07 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036927